The article provides information on the report "Drug Expenditure in Canada, 1985 to 2011" from the Canada Institute for Health Information. According to the report, there has been a slow down in the rate of Canadian pharmaceutical spending in 2011 due to the expiry of patent protection for several drugs. The report also shows that the share of generics in the Canadian prescription drug market is expected to rise in the coming years.